Respiratory Movement of Upper Abdominal Organs and its Effect on Radiotherapy Planning in Pancreatic Cancer1

Clinical Oncology

Volumn 21, Issue 9, 2009, Pages 713-719

  Gwynne, S ^a   Wills, L ^a   Joseph, G ^a   John, G ^a   Staffurth, J ^a   Hurt, C ^b   Mukherjee, S ^a  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Individualised margins; pancreas; radiotherapy

Indexed keywords

GEMCITABINE;

ADULT; AGED; ARTICLE; BREATHING MECHANICS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; KIDNEY; LIVER; MALE; ORGAN; PANCREAS CANCER; PERITONEAL CAVITY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SMALL INTESTINE; TREATMENT PLANNING;

AGED; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; MOVEMENT; PANCREATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RESPIRATION; RESPIRATORY-GATED IMAGING TECHNIQUES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349428299     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.07.015     Document Type: Article

References (25)

1. Mukherjee S., Hudson E., Reza S., et al. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-pancreatic pancreatic cancer. Clin Oncol 20 (2008) 535-540
2. Senan S., and Lagerwaard F. Current status of four dimensional computed tomography for high precision radiotherapy. Eur Oncol Dis 2 (2006) 88-92
3. Hughes S., McClelland J., Chandler A., et al. A comparison of internal target volume definition by limited 4 dimensional computed tomography, the addition of patient-specific margins or the addition of generic margins when planning radical radiotherapy for lymph node positive non-small cell lung cancer. Clin Oncol 20 (2008) 293-300
4. Jiang S.B. Radiotherapy of mobile tumours. Semin Radiat Oncol 16 (2006) 239-248
5. Milano M., Chmura S.J., Garofalo M.C., et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 59 (2004) 445-453
6. Bussels B., Goethals L., Feron M., et al. Respiration-induced movement of the upper abdominal organs: a pitfall for the three dimensional conformal radiation treatment of pancreatic cancer. Radiother Oncol 68 (2003) 69-74
7. Bryan P.J., Custar S., Haaga J.R., et al. Respiratory movement of the pancreas: an ultrasonic study. J Ultrasound Med 3 (1984) 317-320
8. Bhasin D.K., Rana S.S., Jahagirdar S., et al. Does the pancreas move with respiration?. J Gastroenterol Hepatol 21 (2006) 1424-1427
9. Gierga D.P., Chen G.T., Kung J.H., et al. Quantification of respiration induced abdominal tumour motion and its impact on IMRT dose distributions. Int J Radiat Oncol Biol Phys 58 5 (2004) 1584-1595
10. Ahn Y.C., Shimizu S., Shirato H., et al. Application of real-time tumour tracking and gated radiotherapy system for unresectable pancreatic cancer. Yonsei Med J 45 (2004) 584-590
11. International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording and reporting photon beam therapy. Report 50 (1993), ICRU, Bethesda
12. International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording and reporting photon beam therapy. Report 62, supplement to Report 50 (1999), ICRU, Bethesda
13. Zaki B., Fanous S., Gordon T., et al. Assessment of pancreatic motion using daily X-ray imaging of biliary stents as fiducials during the course of radiation therapy for localised pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 69 Suppl. 1 (2007) S293-S294 [Abstract]
14. Crane C.H., Antolak J.A., Rosen II, et al. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. Int J Gastrointest Cancer 30 (2001) 123-132
15. Henry A., Ryder W., Moore C., et al. Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study. Clin Oncol 20 (2008) 541-547
16. Ozhasoglu C., and Murphy M.J. Issues in respiratory motion compensation during external beam radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 1380-1399
17. Jansen E.P., Saunders M.P., Boot H., et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 67 (2007) 781-785
18. Fuss M., Salter B.J., Cavanaugh S.X., et al. Daily ultrasound based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 59 (2004) 1245-1256
19. Landry J.C., Yang G.Y., Ting J.Y., et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosim 27 (2002) 121-129
20. Ben-Joseph E., Shields A.F., Vaishampayan U., et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59 2 (2004) 454-459
21. Nelson C., Balter P., Morice R.C., et al. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumour using implanted fiducials. J Appl Clin Med Phys 9 4 (2008) 2766
22. Mancosu P., Bettinardi V., Passoni P., et al. Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. Radiother Oncol 87 (2008) 339-342
23. Hunjan S., Starkschall G., Rosen I., et al. Comparison of breath-hold and free-breathing positions of an extran fiducial by analysis of respiratory traces. J Appl Clin Med Phys 9 3 (2008) 2768
24. Gierga D.P., Brewer J., Sharp G.C., et al. The correlation between internal and external markers for abdominal tumors: implications for respiratory gating. Int J Radiat Oncol Biol Phys 61 5 (2005) 1551-1558
25. Kutcher G.J., Mageras G.S., and Leibel S.A. Control, correction and modelling of set up errors and organ motion. Semin Radiat Oncol 5 (1995) 134-145